Gutiérrez-Delgado Eva M, Treviño-González José Luis, Montemayor-Alatorre Adolfo, Ceceñas-Falcón Luis Angel, Ruiz-Holguín Eduardo, Andrade-Vázquez Catalina Janette, Lara-Medrano Reynaldo, Ramos-Jiménez Javier
Infectious Diseases Division, Internal Medicine Department, University Hospital "Dr. José Eleuterio González" of the Autonomous University of Nuevo León, Gonzalitos Y Madero SN, Mitras Centro, Monterrey, CP 64460, NL, Mexico.
Otolaryngology-Head and Neck Surgery Department, University Hospital "Dr. José Eleuterio González" of the Autonomous University of Nuevo León, Gonzalitos Y Madero SN, Mitras Centro, Monterrey, CP, 64460, NL, Mexico.
Ann Med Surg (Lond). 2016 Feb 6;6:87-91. doi: 10.1016/j.amsu.2016.02.003. eCollection 2016 Mar.
Mucormycosis is a life-threatening disease, were rhinocerebral infection is most commonly seen in the clinical setting. Chronic mucormycosis is a rare presentation that exhibits a challenging diagnosis. We describe the case of a 47 year old diabetic man with complains of left zygomatic arch swelling of 3 months evolution. He had received previous antibiotic treatment without improvement. Biopsy of maxillary sinus revealed the presence of non-septated, 90° angle branched hyphae compatible with zygomicetes. The patient was treated with surgical debridement and amphotericin B until there was no evidence of fungi in the tissue by biopsy. We reviewed chronic rhino-orbito-cerebral mucormycosis from 1964-2014 and 22 cases were found, being this the second case of chronic mucormycosis reported in Mexico. A quarter of the cases were seen in immunocompetent hosts. As only 20% of the causal agent can be isolated by culture, the diagnosis is mainly made by biopsy. Besides treatment with amphotericin B, posaconazole as alternative, and control of the underlying comorbidities, surgical debridement represents the corner stone therapy. We recommend at least 36 month follow-up, due to the 13% risk of recurrence. A chronic presentation has a general survival rate of approximately 83%.
毛霉病是一种危及生命的疾病,在临床环境中最常见的是鼻脑感染。慢性毛霉病是一种罕见的表现形式,诊断具有挑战性。我们描述了一名47岁糖尿病男性的病例,他主诉左颧弓肿胀3个月。他之前接受过抗生素治疗但无改善。上颌窦活检显示存在与接合菌相符的无隔膜、呈90°角分支的菌丝。患者接受了手术清创和两性霉素B治疗,直到活检显示组织中没有真菌迹象。我们回顾了1964年至2014年的慢性鼻眶脑毛霉病,共发现22例,这是墨西哥报道的第二例慢性毛霉病。四分之一的病例见于免疫功能正常的宿主。由于只有20%的病原体可通过培养分离出来,诊断主要依靠活检。除了用两性霉素B治疗、泊沙康唑作为替代治疗以及控制潜在的合并症外,手术清创是基石疗法。由于复发风险为13%,我们建议至少随访36个月。慢性表现的总体生存率约为83%。